Reagents and instruments for immunology, cell biology and molecular biology.
 

MedChemExpress

 See all products
 
Website: 
 
SARS-CoV-2 - Ruxolitinib - Therapeutic Candidates

SARS-CoV-2 - Ruxolitinib - Therapeutic Candidates

Search result : 34 product found

Refine your search :

RUOCE / IVD
  • Unconjugated 21
  • Inhibitor/Antagonist/Agonist 29
  • Biochemicals 5
APPLY FILTERS
REINITIALIZE


Cat#
Description
Cond.
Price Bef. VAT
HY-50856-5mg
Ruxolitinib [941678-49-5]
 5mg 
HY-50856-1ml
Ruxolitinib [941678-49-5]
 10mM/1mL 
HY-50856-500mg
Ruxolitinib [941678-49-5]
 500mg 
HY-50856-10mg
Ruxolitinib [941678-49-5]
 10mg 
HY-50856-50mg
Ruxolitinib [941678-49-5]
 50mg 
HY-50856-1mg
Ruxolitinib [941678-49-5]
 1mg 
HY-50856-100mg
Ruxolitinib [941678-49-5]
 100mg 
HY-50856-200mg
Ruxolitinib [941678-49-5]
 200mg 
HY-50856R-5mg
Ruxolitinib (Standard) [941678-49-5]
 5mg 
HY-50859
Ruxolitinib (sulfate) [1092939-16-6]
 Getquote 
HY-50856R-50mg
Ruxolitinib (Standard) [941678-49-5]
 50mg 
HY-50856R-25mg
Ruxolitinib (Standard) [941678-49-5]
 25mg 
HY-50856R-10mg
Ruxolitinib (Standard) [941678-49-5]
 10mg 
HY-50856A-100mg
Ruxolitinib (S enantiomer) [941685-37-6]
 100mg 
HY-50856R-100mg
Ruxolitinib (Standard) [941678-49-5]
 100mg 
HY-50856A-1ml
Ruxolitinib (S enantiomer) [941685-37-6]
 10mM/1mL 
HY-50858-200mg
Ruxolitinib (phosphate) [1092939-17-7]
 200mg 
    ‹
    ›